看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
$ Y j3 F. {& Y- a% [% x6 d3 b
' u" A5 ~8 N4 { z+ F |; j1 O3 C" k
Currently available feasibility data for possible combination strategies.
/ r6 \) d. p# R————————————————————————————————5 g) J' `3 ~6 s6 ^" Q5 p/ s1 J
Combination Feasibility according to preliminary data , a& R* `: e" {
——————————————————————————————————
4 {" Z1 M$ J2 K. D' kBevacizumab + sorafenib Yes, reduced dose
/ X. \- D. I5 T& u$ L* yBevacizumab + sunitinib† No
# l7 N7 t# e: E8 e: RBevacizumab + temsirolimus Yes
5 A t7 K- G! nBevacizumab + everolimus Yes
' t! p' } h& w# w' [2 V" TSorafenib + sunitinib ?
% m% E1 X( b" g ?' ^Sorafenib + temsirolimus Yes, reduced dose
, L- \7 _# L, kSorafenib + everolimus Yes, reduced dose 6 b; N+ C& U( X. i+ t( C
Sunitinib + temsirolimus† No
% K5 @/ e: r7 p- J/ U+ ]Sunitinib + everolimus ? ( |) B& ?) D5 M5 O
Temsirolimus + everolimus ? 2 q; f0 O( l3 l& F
————————————————————4 z8 O5 `. n) a; g
†Led to US FDA warning.
( n9 _$ @: @2 M7 u' }# d( v5 g?: As yet unattempted combination.
* L# \+ D4 A7 j6 O2 G$ L8 G |